From: Becker's Supply Chain Report <editorial@beckershealthcare.com>
Subject: Pharma execs say Intermountain drug venture not a threat | Amazon bans customers with too many returns | Ex-Valeant, Philidor execs found guilty in kickback scheme | Viewpoint: Hospital opioid shortage could leave terminal patients in pain
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube


May 25, 2018
TODAY'S TOP STORIES
1. 72% of pharma execs say Intermountain's drug venture is not a threat

2. Red Cross offers blood donors $5 Amazon gift card to boost summer donations Full story

3. Hospital opioid shortage could leave terminal patients in pain, cancer physician says Full story

4. Learn what over 2,000 Americans had to share about their thoughts on connecting with payers, providers, and life science companies, both currently and in the future. 

5. Man accused of impersonating nurse, responding to emergencies at UPMC hospital Full story   

6. Amazon is banning customers with too many returns: 5 things to know Full story
 
7. For insights into how IT infrastructure can support hospital M&A success, register for this webinar.

8. 25-foot-wide sinkhole appears near Florida hospital Full story
 
9. Ex-Valeant, Philidor execs found guilty in kickback scheme: 6 things to know Full story
 
10. Market share trumps operational efficiency for teaching hospitals, study finds Full story
  
11. Spot trends and opportunities for efficiency in your supply chain Learn more

12. 6 latest FDA approvals Full story


Channels
Contact Us

Editorial Contact: 
Molly Gamble 
Editor-in-Chief
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
 
Becker's Hospital Review
A Becker's Healthcare Publication
  www.BeckersHospitalReview.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact